ALT

Altimmune

• Reuters·6d ago

  U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

• Reuters·6d ago

  ALTIMMUNE INC <ALT.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $20 FROM $25

• Dow Jones·6d ago

  Altimmune Price Target Cut to $20.00/Share From $25.00 by HC Wainwright & Co.

• Dow Jones·6d ago

  Altimmune Is Maintained at Buy by HC Wainwright & Co.

• Benzinga·6d ago

  HC Wainwright & Co. Maintains Buy on Altimmune, Lowers Price Target to $20

• TipRanks·6d ago

  Altimmune price target lowered to $20 from $25 at H.C. Wainwright

• Dow Jones·05/14 14:15

  Altimmune Price Target Cut to $11.00/Share From $14.00 by Citizens

• Dow Jones·05/14 14:15

  Altimmune Is Maintained at Market Outperform by Citizens

• Benzinga·05/14 14:05

  Citizens Maintains Market Outperform on Altimmune, Lowers Price Target to $11

• TipRanks·05/14 12:20

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Altimmune (ALT), Nuwellis (NUWE) and Siegfried Holding AG (OtherSGFEF)

• TipRanks·05/14 09:47

  Altimmune price target lowered to $11 from $14 at Citizens

• TipRanks·05/14 09:20

  Analysts Conflicted on These Healthcare Names: Altimmune (ALT), Brookdale Senior Living (BKD) and Johnson & Johnson (JNJ)

• Seeking Alpha·05/14 04:41

  Altimmune outlines PERFORMA Phase III MASH start in 2H 2026 and cash runway to 2029 52-week readout

• TipRanks·05/14 00:47

  Altimmune Earnings Call: Cash Boost and Phase III Push

• NASDAQ·05/13 20:59

  Altimmune (ALT) Q1 2026 Earnings Transcript